806 related articles for article (PubMed ID: 33593430)
21. Faecalibacterium prausnitzii increases following fecal microbiota transplantation in recurrent Clostridioides difficile infection.
Björkqvist O; Rangel I; Serrander L; Magnusson C; Halfvarson J; Norén T; Bergman-Jungeström M
PLoS One; 2021; 16(4):e0249861. PubMed ID: 33836037
[TBL] [Abstract][Full Text] [Related]
22. Dietary Xanthan Gum Alters Antibiotic Efficacy against the Murine Gut Microbiota and Attenuates
Schnizlein MK; Vendrov KC; Edwards SJ; Martens EC; Young VB
mSphere; 2020 Jan; 5(1):. PubMed ID: 31915217
[TBL] [Abstract][Full Text] [Related]
23. Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile.
Kumar R; Maynard CL; Eipers P; Goldsmith KT; Ptacek T; Grubbs JA; Dixon P; Howard D; Crossman DK; Crowley MR; Benjamin WH; Lefkowitz EJ; Weaver CT; Rodriguez JM; Morrow CD
BMC Microbiol; 2016 Jan; 16():5. PubMed ID: 26758906
[TBL] [Abstract][Full Text] [Related]
24. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.
Staley C; Kelly CR; Brandt LJ; Khoruts A; Sadowsky MJ
mBio; 2016 Dec; 7(6):. PubMed ID: 27999162
[TBL] [Abstract][Full Text] [Related]
25. Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study.
Orenstein R; Dubberke E; Hardi R; Ray A; Mullane K; Pardi DS; Ramesh MS;
Clin Infect Dis; 2016 Mar; 62(5):596-602. PubMed ID: 26565008
[TBL] [Abstract][Full Text] [Related]
26. Computational modeling of the gut microbiota reveals putative metabolic mechanisms of recurrent Clostridioides difficile infection.
Henson MA
PLoS Comput Biol; 2021 Feb; 17(2):e1008782. PubMed ID: 33617526
[TBL] [Abstract][Full Text] [Related]
27. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
Pipek B; Valentová H; Fojtík P; Urban O
Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
[TBL] [Abstract][Full Text] [Related]
28. Microbiota restoration for recurrent Clostridioides difficile: Getting one step closer every day!
Khanna S
J Intern Med; 2021 Aug; 290(2):294-309. PubMed ID: 33856727
[TBL] [Abstract][Full Text] [Related]
29. Functional profile of host microbiome indicates
Nzabarushimana E; Tang H
Gut Microbes; 2022; 14(1):2135963. PubMed ID: 36289064
[TBL] [Abstract][Full Text] [Related]
30. Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.
Kelly CR; Khoruts A; Staley C; Sadowsky MJ; Abd M; Alani M; Bakow B; Curran P; McKenney J; Tisch A; Reinert SE; Machan JT; Brandt LJ
Ann Intern Med; 2016 Nov; 165(9):609-616. PubMed ID: 27547925
[TBL] [Abstract][Full Text] [Related]
31. Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection.
Brown JR; Flemer B; Joyce SA; Zulquernain A; Sheehan D; Shanahan F; O'Toole PW
BMC Gastroenterol; 2018 Aug; 18(1):131. PubMed ID: 30153805
[TBL] [Abstract][Full Text] [Related]
32. The Initial Gut Microbiota and Response to Antibiotic Perturbation Influence Clostridioides difficile Clearance in Mice.
Tomkovich S; Stough JMA; Bishop L; Schloss PD
mSphere; 2020 Oct; 5(5):. PubMed ID: 33087520
[TBL] [Abstract][Full Text] [Related]
33. Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660-A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection.
Dubberke ER; Lee CH; Orenstein R; Khanna S; Hecht G; Gerding DN
Clin Infect Dis; 2018 Sep; 67(8):1198-1204. PubMed ID: 29617739
[TBL] [Abstract][Full Text] [Related]
34. Systems biology evaluation of refractory Clostridioides difficile infection including multiple failures of fecal microbiota transplantation.
Gonzales-Luna AJ; Spinler JK; Oezguen N; Khan MAW; Danhof HA; Endres BT; Alam MJ; Begum K; Lancaster C; Costa GP; Savidge TC; Hurdle JG; Britton R; Garey KW
Anaerobe; 2021 Aug; 70():102387. PubMed ID: 34044101
[TBL] [Abstract][Full Text] [Related]
35. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
[TBL] [Abstract][Full Text] [Related]
36. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
Konturek PC; Koziel J; Dieterich W; Haziri D; Wirtz S; Glowczyk I; Konturek K; Neurath MF; Zopf Y
J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
[TBL] [Abstract][Full Text] [Related]
37. Restoration of Bacterial Microbiome Composition and Diversity Among Treatment Responders in a Phase 2 Trial of RBX2660: An Investigational Microbiome Restoration Therapeutic.
Blount KF; Shannon WD; Deych E; Jones C
Open Forum Infect Dis; 2019 Apr; 6(4):ofz095. PubMed ID: 31024971
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection.
Hirsch BE; Saraiya N; Poeth K; Schwartz RM; Epstein ME; Honig G
BMC Infect Dis; 2015 Apr; 15():191. PubMed ID: 25885020
[TBL] [Abstract][Full Text] [Related]
39. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection.
Weingarden AR; Chen C; Bobr A; Yao D; Lu Y; Nelson VM; Sadowsky MJ; Khoruts A
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G310-9. PubMed ID: 24284963
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial Resistance Gene Acquisition and Depletion Following Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
Leung V; Vincent C; Edens TJ; Miller M; Manges AR
Clin Infect Dis; 2018 Jan; 66(3):456-457. PubMed ID: 29020222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]